Table 3 Distribution of weight z-scores of treated and untreated MPS II patients at baseline, year 1, and year 2 of follow up as classified in to age groups
All (n = 11) | Treated (n = 2) | Untreated (n = 9) | |
|---|---|---|---|
Group 1 | |||
Baseline | |||
Underweight (z < − 2) % | 0 | 0 | 0 |
Normal (z < − 1 to + 2) % | 9 81.9% | 2 100% | 7 77.78% |
Overweight (z > + 2) % | 2 18.1% | 0 | 2 22.22% |
Year 1 | |||
Underweight (z < − 2) % | 1 9% | 0 | 1 11.11% |
Normal (z < − 1 to + 2) % | 8 72.72 | 2 100% | 6 66.67% |
Overweight (z > + 2) % | 2 18.18 | 0 | 2 22.22 |
Year 2 | |||
Underweight (z < − 2) % | 1 9% | 0 | 1 11.11% |
Normal (z < − 1 to + 2) % | 9 81.9% | 2 100% | 7 77.78% |
Overweight (z > + 2) % | 1 9% | 0 | 1 11.11% |
Group 2 | |||
Baseline (n = 16; Treated = 1; Untreated = 15) | |||
Underweight (z < − 2) % | 3 18.75% | 1 | 2 13.33% |
Normal (z < − 1 to + 2) % | 13 81.25% | 0 | 13 86.67% |
Overweight (z > + 2) % | 0 | 0 | 0 |
Year 1 (n = 13; Treated = 1; Untreated = 12) | |||
Underweight (z < − 2) % | 4 30.77% | 1 | 3 25% |
Normal (z < − 1 to + 2) % | 9 69.23% | 0 | 9 75% |
Overweight (z > + 2) % | 0 | 0 | 0 |
Year 2 (n = 11; Treated = 0; Untreated = 11) | |||
Underweight (z < − 2) % | 5 45.45% | NA | 5 45.45% |
Normal (z < − 1 to + 2) % | 6 54.54% | NA | 6 54.54% |
Overweight (z > + 2) % | 0 | NA | 0 |
Group 3 | |||
Baseline (n = 13; Treated = 5; Untreated = 8) | |||
Underweight (z < − 2) % | 10 76.9% | 4 80% | 6 75% |
Normal (z < − 1 to + 2) % | 3 23.2% | 1 20% | 2 25% |
Overweight (z > + 2) % | 0 | 0 | 0 |
Year 1 (n = 12; Treated = 5; Untreated = 7) | |||
Underweight (z < − 2) % | 11 91.67% | 4 80% | 7 100% |
Normal (z < − 1 to + 2) % | 1 12.5% | 1 20% | 0 |
Overweight (z > + 2) % | 0 | 0 | 0 |
Year 2 (n = 8; Treated = 4; Untreated = 4) | |||
Underweight (z < − 2) % | 7 87.5% | 3 75% | 4 100% |
Normal (z < − 1 to + 2) % | 1 12.5% | 1 25% | 0 |
Overweight (z > + 2) % | 0 | 0 | 0 |